{"disease":{"id":"acquired-bleeding-disorder","name":"acquired bleeding disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT00124293","title":"Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01564563","title":"Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}